cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Aurinia Pharmaceuticals Inc
42 own
63 watching
Current Price
$4.99
$0.18
(3.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,338.43M
52-Week High
52-Week High
12.43000
52-Week Low
52-Week Low
4.71000
Average Volume
Average Volume
1.55M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,338.43M
icon52-Week High12.43000
icon52-Week Low4.71000
iconAverage Volume1.55M
iconDividend Yield--
iconP/E Ratio--
What does the Aurinia Pharmaceuticals Inc do?
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Read More
How much money does Aurinia Pharmaceuticals Inc make?
News & Events about Aurinia Pharmaceuticals Inc.
Business Wire
11 months ago
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization of LUPKYNIS (voclosporin) in combination with a background immunosuppressive therapy to treat adults with active class...
Business Wire
11 months ago
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Glass Lewis & Co. (Glass Lewis), a leading independent proxy advisor, has recommended that Aurinia shareholders vote FOR ALL proposals at the Companys 2023 Annual General Meeting (the Meeting...
Business Wire
12 months ago
Toni Braxton, the award-winning singer, songwriter, actress, producer, and entrepreneur is speaking out about living with lupus and the importance of prioritizing kidney health. In partnership with Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a biopharmaceutical company committed to changing the...
Business Wire
1 year ago
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the United States Patent and Trademark Office (USPTO) has issued a new and refined method of use patent titled IMPROVED PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS. Aurinias newly issued U.S. Patent (No...
Zolmax
1 year ago
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH Get Rating) (TSX:AUP) has earned an average recommendation of Moderate Buy from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and four have assigned a buy ...
Frequently Asked Questions
Frequently Asked Questions
What is Aurinia Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Aurinia Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Aurinia Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Aurinia Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Aurinia Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Aurinia Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Aurinia Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Aurinia Pharmaceuticals Inc?
plus_minus_icon
What percentage is Aurinia Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Aurinia Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.99
$0.18
(3.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00